 |
|
|
|
|
|
|
| J.D. Horton. 2008. Physiology: Unfolding Lipid Metabolism.
Science. 320:1433-4. |
|
|
|
K. Minehira, S.G. Young, C.J. Villanueva, L. Yetukuri, M. Oresic, M.K. Hellerstein, R.V. Farese, Jr., J.D. Horton, F. Preitner, B. Thorens, L. Tappy. 2008. Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice.
J. Lipid Res.. Jun 1 [Epub ahead of print]. |
|
| Z. Zhao, Y. Tuakli-Wosornu, T.A. Lagace, L. Kinch, N.V. Grishin, J.D. Horton, J.C. Cohen, H.H. Hobbs. 2006. Molecular characterization of loss-of-function mutations in PCSK9 and
identification of a compound heterozygote.
Am. J. Hum. Genet. 79:514-523. |
|
T. A. Lagace, D. E. Curtis, R. Garuti, M. C. McNutt, S. W. Park, H. B. Prather, N. N. Anderson, Y. K. Ho, R. E. Hammer, and J. D. Horton. 2006. Secreted PCSK9 decreases LDL receptors in hepatocytes and livers of parabiotic mice. J. Clin. Invest. 116:2995-3005.
|
|
J.D. Horton, J.C. Cohen, H.H. Hobbs. 2007. Molecular biology of PCSK9: its role in LDL metabolism.
Trends Biochem Sci. 32:71-77.
|
|
D.W. Zhang, T.A. Lagace, R. Garuti, Z. Zhao, M. McDonald, J.D. Horton, J.C. Cohen, H.H. Hobbs. 2007. Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation.
J. Biol. Chem. 282:18602-18612.
|
|
M.C. McNutt, T.A. Lagace, J.D. Horton. 2007. Catalytic Activity Is Not Required for Secreted PCSK9 to Reduce Low Density Lipoprotein Receptors in HepG2 Cells.
J. Biol. Chem. 282:20799-20803.
|
|
M. John, R. Constien, A. Akinc, M. Goldberg, Y.A. Moon, M. Spranger, P. Hadwiger, J. Soutschek, H.P. Vomlocher, M. Manoharan, M. Stoffel, R. Langer, D.G. Anderson, J.D. Horton, V. Kotelianksky, and D. Bumcrot. 2007. Effective RNAi-mediated gene silencing without interruption of the endogenous
microRNA pathway.
Nature 449:745-747.
|
|
H.J. Kwon, T.A. Lagace, M.C. McNutt, J.D. Horton., J. Deisenhofer. 2008. Molecular basis for LDL receptor recognition by PCSK9.
Proc. Natl. Acad. Sci. USA. 105:1820-1825.
|
|
Grefhorst, A., McNutt, M.C., Lagace, T.A., Horton, J.D. 2008. Plasma PCSK9 preferentially reduces liver LDL receptors in mice.
J. Lipid. Res., 2008 Mar 19, [Epub ahead of print].
|
|
|
SIGNIFICANT PUBLICATIONS
|
|
J.D. Horton, Y. Bashmakov, I. Shimomura and H. Shimano. 1998. Regulation of sterol regulatory element binding
proteins in livers of fasted and refed mice. Proc. Natl. Acad. Sci. USA. 95:5987-5992.
|
|
|
I. Shimomura, Y. Bashmakov and J.D. Horton. 1999. Increased levels of nuclear SREBP-1c associated with
fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 274:30028-30032. |
|
|
Y-A. Moon, N.A. Shah, S. Mohapatra,
J.A. Warrington and J.D. Horton. 2001. Identification of a
mammalian long chain fatty acyl elongase regulated by sterol
regulatory element-binding proteins. J. Biol. Chem.
276:45358-45366.
|
|
|
J.D. Horton, N.A. Shah, J.A. Warrington,
N.N. Anderson, S.W. Park, M.S. Brown, and J.L. Goldstein.
2003. Combined analysis of oligonucleotide microarray data
from transgenic and knockout mice identifies direct SREBP
target genes. Proc. Natl. Acad. Sci. USA. 100:12027-12032.
|
|
T.A. Lagace, D.E. Curtis, R. Garuti, M.C. McNutt, S.W. Park, H.B. Prather, N.N. Anderson, Y.K. Ho, R.E. Hammer, and J.D. Horton. 2006.
Secreted PCSK9 decreases LDL receptors in hepatocytes and livers of parabiotic mice. J. Clin. Invest. 116:2995-3005 .
|
|
|
|
